ENSC - Ensysce Biosciences Inc

https://www.ensysce.com

Momentum: Bearish

Recent News

Why Is Ensysce Biosciences Stock Skyrocketing On Wednesday? - Ensysce Biosciences ( NASDAQ:ENSC )

Benzinga • 4 months, 3 weeks ago • score: 0.38

Ensysce stock trades up with 26.79 million volume, far exceeding the 81.23K average. PF614-MPAR showed reduced oxycodone release in overdose scenarios during trials. Don't face extreme market conditions unprepared.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California.

52W High

$14.67

52W Low

$1.62

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.01

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

12.20

EV/EBITDA (<8 favorable)

-0.50

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

0.86

P/B (<3 favorable)

1.87

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.35%

Institutions (25–75% balanced)

6.04%

Shares Outstanding

2,968,400

Float

2,546,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

7,413,700

Gross Profit (TTM)

-1,888,539

EPS (TTM)

-3.51

Profit Margin (>10% good)

-0.89%

Operating Margin (TTM) (higher better)

-1.28%

ROE (TTM) (>15% strong)

-2.90%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

6.54

Momentum

Bearish momentum

Value

0.0016

0.0028

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025